PsychoPharm aggregated risk score (PARS): a multidimensional tool to flag high-risk pharmacotherapy in psychiatric patients. [PDF]
Goldiş FD +4 more
europepmc +1 more source
SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington's disease models. [PDF]
Lu M +11 more
europepmc +1 more source
Case Report: Neuropsychiatric instability in structurally compromised CNS Erdheim-Chester disease: a diagnostic and management challenge. [PDF]
Alfraiji AF +3 more
europepmc +1 more source
Persistent auditory hallucinations despite hearing aid use in bilateral sensorineural hearing loss without evidence of psychosis. [PDF]
Elhusein B +3 more
europepmc +1 more source
QTc interval prolongation in ICU patients: risk assessment and predictors. [PDF]
Awan MAS +8 more
europepmc +1 more source
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis. [PDF]
Furukawa Y +9 more
europepmc +1 more source
The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with Schizophrenia. [PDF]
Dickerson F +7 more
europepmc +1 more source
Congenital malformation risk following prenatal antipsychotic exposure: a systematic safety surveillance approach. [PDF]
Straub L +10 more
europepmc +1 more source
Evolution of a central dopamine circuit underlies adaptation of a light-evoked sensorimotor response in the blind cavefish. [PDF]
Kozol RA +5 more
europepmc +1 more source
Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a Pediatric Patient Receiving Fluoxetine and Haloperidol: A Case Report. [PDF]
Aráez PMB, Turner S.
europepmc +1 more source

